Rebecca Quick

Rebecca Quick is an accomplished professional in clinical operations and regulatory affairs, currently serving as the Director of Clinical Operations at Alnylam Pharmaceuticals since March 2025. Prior to this role, Rebecca held various senior positions at Sanofi from September 2017 to March 2025, including Regulatory Vendor Manager Lead, where responsibilities included managing key providers for the Global Regulatory Affairs division, and Director of Global LEAD for the FSP Partnership, overseeing a significant budget and a large team for clinical study monitoring services. Additionally, as Head of US Strategic Partnerships and Interim UC Country Head, Rebecca led operational efforts for North American clinical studies, managing resource allocation and optimizing processes. Rebecca holds a Bachelor of Science degree in Public Health from Stockton University, completed in May 1996.